ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 116 filers reported holding ENZO BIOCHEM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $264,000 | -67.5% | 125,292 | -65.5% | 0.00% | -50.0% |
| Q2 2020 | $813,000 | +1526.0% | 363,333 | +2839.6% | 0.00% | – |
| Q3 2018 | $50,000 | -91.6% | 12,360 | -89.2% | 0.00% | -100.0% |
| Q2 2018 | $593,000 | -23.4% | 114,518 | -18.9% | 0.00% | 0.0% |
| Q1 2018 | $774,000 | -40.0% | 141,284 | -8.7% | 0.00% | -50.0% |
| Q4 2017 | $1,289,000 | -47.4% | 154,733 | -33.9% | 0.00% | -50.0% |
| Q3 2017 | $2,451,000 | -1.7% | 234,115 | +3.7% | 0.00% | 0.0% |
| Q2 2017 | $2,493,000 | +64.6% | 225,831 | +24.8% | 0.00% | +33.3% |
| Q1 2017 | $1,515,000 | +41.3% | 180,973 | +16.9% | 0.00% | +50.0% |
| Q4 2016 | $1,072,000 | – | 154,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
| Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
| Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
| CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
| MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
| EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
| Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
| HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
| Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |